What’s Achieve Life Sciences, Inc. (ACHV) Downside After Today’s Huge Decline?

June 14, 2018 - By James Guidry

The stock of Achieve Life Sciences, Inc. (NASDAQ:ACHV) is a huge mover today! The stock decreased 25.18% or $1.75 during the last trading session, reaching $5.2. About 230,405 shares traded or 357.95% up from the average. Achieve Life Sciences, Inc. (NASDAQ:ACHV) has declined 74.49% since June 15, 2017 and is downtrending. It has underperformed by 87.06% the S&P500.
The move comes after 9 months negative chart setup for the $6.71M company. It was reported on Jun, 15 by Barchart.com. We have $4.73 PT which if reached, will make NASDAQ:ACHV worth $604,080 less.

More important recent Achieve Life Sciences, Inc. (NASDAQ:ACHV) news were published by: Benzinga.com which released: “42 Stocks Moving In Thursday’s Mid-Day Session” on May 24, 2018, also Prnewswire.com published article titled: “Achieve Life Sciences, Inc. Announces Reverse Stock Split”, Benzinga.com published: “31 Stocks Moving In Thursday’s Mid-Day Session” on June 14, 2018. More interesting news about Achieve Life Sciences, Inc. (NASDAQ:ACHV) was released by: Benzinga.com and their article: “28 Stocks Moving In Wednesday’s Mid-Day Session” with publication date: June 06, 2018.

Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. The company has market cap of $6.71 million. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.